- Grants
- Loans & Scholarships
- Data Warehouse
- Training & TA Hub
- Behavioral Health
- Care Teams
- Child and Adolescent Health
- Chronic and Infectious Diseases
- Financing
- Health Information Technology
- HIV/AIDS
- Maternal Health
- Older Adult Health
- Oral Health
- Performance Measurement & Quality Improvement
- Research
- Rural Health
- Social Determinants of Health
- Telehealth
- Training Centers
- Workforce
- About HRSA
FAQs for COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment and Vaccine Administration
Catalog of Federal Domestic Assistance number (CFDA): 93.461
Eligibility Questions
The American Rescue Plan Act of 2021 (ARPA, P.L. 117-2) included a requirement that most Medicaid limited-benefit plans cover COVID-19 vaccine administration, effective March 11, 2021. ARPA also required Medicaid limited COVID-19 testing plans to cover COVID-19 treatment. For more information, see the CMCS Informational Bulletin (PDF - 312 KB).
The HRSA COVID-19 Uninsured Program reimburses eligible claims for COVID-19 testing, treatment, and vaccination for individuals with limited Medicaid benefits if the Medicaid plan does not cover these services. HRSA's contractor, UnitedHealth Group (UHG), checks if the patient on the claim has other health care coverage using standard eligibility transactions. Currently, if UHG finds the patient has Medicaid coverage with limited benefits, the program reimburses the claim if otherwise eligible, but conducts coordination of benefits after payment to verify the patient’s Medicaid plan did not cover the COVID-19 services on the claim. If the Medicaid plan covered services that the Uninsured Program reimbursed, the program would offset the overpayment against any pending claims from the provider; if an offset is not possible, the provider must return the overpayment.

Connect with HRSA
